Phibro Animal Health Corp (PAHC) stock
PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)
Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%
Phibro Animal Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Phibro Animal Health's ebitda for the twelve months ending Jun 30, 2026 was $245.91M, up 57.6% year over year. For fiscal 2026 it was $245.91M, up 57.6% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $245.91M in fiscal 2026.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $245.91M | +57.6% |
| FY2025 | Jun 30, 2025 | $156.07M | +74.4% |
| FY2024 | Jun 30, 2024 | $89.49M | -15.5% |
| FY2023 | Jun 30, 2023 | $105.86M | -5.2% |
| FY2022 | Jun 30, 2022 | $111.69M | +4.6% |
| FY2021 | Jun 30, 2021 | $106.75M | +5.1% |
| FY2020 | Jun 30, 2020 | $101.54M | -8.4% |
| FY2019 | Jun 30, 2019 | $110.79M | -12.0% |
| FY2018 | Jun 30, 2018 | $125.87M | +1.6% |
| FY2017 | Jun 30, 2017 | $123.94M | +13.5% |
| FY2016 | Jun 30, 2016 | $109.20M | -0.1% |
| FY2015 | Jun 30, 2015 | $109.27M | +28.2% |
| FY2014 | Jun 30, 2014 | $85.25M | +12.5% |
| FY2013 | Jun 30, 2013 | $75.75M | +13.3% |
| FY2012 | Jun 30, 2012 | $66.85M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $61.50M | +33.3% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $57.10M | +23.8% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $63.22M | +70.4% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $64.09M | +140.0% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $46.13M | +67.0% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $46.13M | +58.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $37.11M | +50.8% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $26.70M | +227.8% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $27.62M | -14.6% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $29.12M | +7.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $24.61M | +1.1% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $8.15M | -63.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $32.34M | +3.4% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $27.04M | -2.2% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $24.34M | -19.6% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $22.13M | -1.5% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $31.29M | +15.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $27.64M | -1.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $30.30M | +8.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $22.47M | -5.3% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $27.00M | +2.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $28.05M | -5.1% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $27.98M | +0.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $23.72M | +32.3% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $26.28M | +36.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $29.57M | +0.4% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $27.76M | -14.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $17.93M | -39.3% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $19.26M | -41.7% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $29.44M | -11.4% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $32.55M | +6.5% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $29.54M | +1.8% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $33.03M | +10.4% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $33.24M | -9.7% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $30.57M | +5.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $29.03M | +3.2% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $29.92M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $36.82M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $29.07M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $28.13M | – |
See a number that looks wrong?